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Does service timing matter for
psychological outcomes in cardiac
rehabilitation? Insights from the National
Audit of Cardiac Rehabilitation
Jennifer Sumner1,2, Jan R Bo¨hnke1,3 and Patrick Doherty1
Abstract
Background: The presence of mental health conditions in cardiac rehabilitation (CR) patients such as anxiety and
depression can lead to reduced programme adherence, increased mortality and increased re-occurrence of cardiovas-
cular events undermining the aims and benefit of CR. Earlier research has identified a relationship between delayed
commencement of CR and poorer physical activity outcomes. This study wished to explore whether a similar relation-
ship between CR wait time and mental health outcomes can be found and to what degree participation in CR varies by
mental health status.
Methods: Data from the UK National Audit of Cardiac Rehabilitation, a dataset that captures information on routine
CR practice and patient outcomes, was extracted between 2012 and 2016. Logistic and multinomial regression models
were used to explore the relationship between timing of CR and mental health outcomes measured on the hospital
anxiety and depression scale.
Results: The results of this study showed participation in CR varied by mental health status, particularly in relation to
completion of CR, with a higher proportion of non-completers with symptoms of anxiety (5% higher) and symptoms of
depression (8% higher). Regression analyses also revealed that delays to CR commencement significantly impact mental
health outcomes post-CR.
Conclusion: In these analyses CR wait time has been shown to predict the outcome of anxiety and depression status to
the extent that delays in starting CR are detrimental. Programmes falling outside the 4-week window for commencement
of CR following referral must strive to reduce wait times to avoid negative impacts to patient outcome.
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Introduction
An estimated 85 million people in Europe live with
cardiovascular disease.1 As survival rates improve, fol-
lowing acute cardiac events, this number is only set to
rise.2 Although improvements in life expectancy are
positive, with increasing age multimorbidity i.e. living
with more than one chronic condition becomes more
common.3 For example frequently those with chronic
conditions experience mental health problems such as
depression and anxiety.4 A systematic review of depres-
sion prevalence in acute myocardial infarction sur-
vivors reported major depression was present in
19.8% of the population and the proportion with
signiﬁcant symptoms varied between 15% and 31%
depending on the type of screening instrument used.5
Comorbid depression and anxiety are especially con-
cerning: impacting quality of life, persisting for long
periods of time, are associated with increased
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healthcare costs6,7 and elevated mortality.4,8,9 A higher
lifetime risk of depressive or anxiety disorders has also
been observed in those with a history of cardiovascular
disease.10
In light of increasingly multimorbid populations
cardiac rehabilitation (CR) has long since shifted from
its origins as a pure exercise regime. In 2000 the national
service framework for coronary heart disease was pub-
lished in the UK, detailing modern standards of care,
including CR services.11 This was followed in 2003 by
a position statement by the European Society of
Cardiology, which provided recommendations on the
design and development of CR programmes.12 CR in
Europe is now expected to be multi-component and
multidisciplinary typically including education and psy-
chological support.13 As part of modern practice, base-
line assessments including the hospital anxiety and
depression scale (HADS)14,15 are conducted upon enrol-
ment to CR in the UK. The HADS has been shown to
be appropriate for screening and as a patient-reported
outcome in cardiac populations.16 Its use means partici-
pants’ care can be tailored to the needs of the individual
patient such as providing psychological support.
For successful CR appropriate management of
mental health conditions is critical.17 The presence of
anxiety or depression may exacerbate the underlying
cardiac condition through reduced programme adher-
ence, lower use of medical care and the pursuit of
unhealthy behaviours such as smoking.4,18 The
presence of anxiety and depression has also been
linked to increased mortality and re-occurrence of car-
diovascular events.19–22 Thus, ineﬀective identiﬁcation
and treatment of comorbid depression and anxiety
undermines the goals of CR.23
In order to deliver successful CR it is important to
identify factors which impact mental health. Previous
research on CR services has found associations between
CR wait time and physical activity outcomes, showing
that longer wait times signiﬁcantly reduce the likeli-
hood of improvement in ﬁtness-related measures.24
In this study we explore whether programme delivery,
in particular timing, may also impact mental health
outcome and how participation in CR may diﬀer
between symptomatic and non-symptomatic patients.
In particular, this study investigates the participation
of patients eligible for CR with and without symptoms
of anxiety and depression and whether delays in initiat-
ing care predict mental health outcome following CR,
measured using HADS.
Methods
This study is reported according to the strengthening
the reporting of observational studies in epidemiology
(STROBE) checklist.25 In the UK CR is delivered in
accordance with national standards and for most
patients includes centre-based CR (80%) with an emer-
ging trend for home-based self-management
approaches.13,26–28 Ideally, programmes should run for
12 weeks twice weekly and consist of multiple compo-
nents: physical activity, education, dietary modiﬁcation
and psychological support.13,29,30 Data on service deliv-
ery, utilisation, patient characteristics and their respect-
ive outcomes are entered onto the National Audit of
Cardiac Rehabilitation (NACR) by practitioners
involved in CR delivery, according to a data dictionary
(http://www.cardiacrehabilitation.org.uk/nacr/downloads.
htm). Participation in NACR is high: in 2016 an average
of 72% of all CR programmes entered data onto the
NACR dataset.31 Typically, CR-indicated patients are
approached by the CR team and referred to the service
while the patient is still in hospital after the acute treat-
ment phase or shortly after discharge. For those that
enroll a pre-assessment takes place, during which patient
sociodemographic and clinical characteristics are recorded.
Following completion of the CR programme the clinical
assessment is repeated.
Participants
Data from the NACR was extracted from 1 January
2012 to 31 August 2016. Adult patients (18 years)
with acute coronary syndrome were included. During
the study period 137,178 patients started core CR and
93,870 completed core CR. Patients who started CR
and had a completed baseline HADS assessment were
included in the investigation of CR participation
(N¼ 56,233). A total of 39,588 patients started and
completed CR and had both a baseline and post-CR
HADS assessment. These patients formed the main
analysis sample. For analyses of the association
between CR wait time and mental health outcome
missing data were imputed for those who started and
completed CR in centres with data for least 10 patients,
generating a sample of 92,086 for a sensitivity analysis.
Measures
Current guidance states that patients should be seen
early by the outpatient CR team and start CR within
4 weeks of referral, and ideally run for 12 weeks twice
weekly.13,26,29,32,33 Three variables were deﬁned to cap-
ture participation in CR: (a) wait time, i.e. time between
referral to CR and start of CR; (b) duration of CR
(days), i.e. between start and end date of CR exceeding
7 days; and (c) non-completion of CR deﬁned as those
with a CR start date entry but no completion date. For
the regression analyses CR wait time (i.e. time between
referral and CR start) was included as a continuous vari-
able (days) to determine the impact on HADS outcome
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for each single day increase in CR wait time, and separ-
ately as a categorical variable to assess the impact of CR
wait time according to current recommendations (on time
0–28 days, delayed 29–365 days). Some CR patients
undergo more invasive surgical procedures as part of
treatment such as bypass surgery, i.e. coronary artery
bypass graft (CABG). For these patients timing cate-
gories were adjusted as recovery from surgery (e.g. ster-
notomy) takes longer and is an important step before
rehabilitation can commence. For CABG patients
timing groups were deﬁned as ‘on time’ 0–42 days and
‘delayed’ 43–365 days.
The HADS14 is a screening tool for symptoms of anx-
iety and depression. It is typically self-completed by
patients under the guidance of a trained medical profes-
sional. The HADS consists of 14 statements of which
seven describe symptoms connected to depression (e.g.
‘I feel as if I am slowed down’) and seven are anxiety
related (e.g. ‘I feel tense or wound up’). Patients respond
on four categorical anchors (coded from 0 to 3). No
individual item data were available to evaluate the reli-
ability of HADS scores in the audit sample, but it has
previously been found to be acceptable.34 The correl-
ation between baseline and post-CR assessments was
0.73 (95% conﬁdence interval (CI) 0.72–0.73).
In our main analysis anxiety and depression scores
were analysed categorically (no symptoms/symptomspre-
sent) according to established clinical cut-oﬀs with scores
less than 8 representing low or no symptoms of anxiety or
depression.14,15 Changes in HADS category between pre
and post-CR were also derived and categorised as: (a)
‘symptomatic to non-symptomatic’; (b) ‘no change in
symptomatic patients’; (c) ‘non-symptomatic to symp-
tomatic’; (d) ‘no change in non-symptomatic patients’.
Statistics
All analyses were conducted using STATA version
14.2. Summary statistics are presented as mean with
standard deviation (SD), medians with interquartile
ranges or percentages as appropriate. The median
time until start of CR and duration of CR were calcu-
lated overall and by anxiety and depression classiﬁca-
tions. Chi-squared or rank sum tests were used to
investigate the statistical diﬀerence between symptomatic
and non-symptomatic participants and a t-test was used
to compare pre and post-CR HADS scores. Logistic
regression analyseswere performed to investigate the rela-
tionship between CR wait time and post-CR outcome
(HADS category), and multinomial logistic regression
models with ‘non-symptomatic to symptomatic’ as a
reference category were used for change in anxiety
and depression between pre and post-CR. Both
analyses were adjusted for age, gender, number of
comorbidities (0–5þ) calculated from 19 prespeciﬁed
comorbidity options as detailed in the NACR data dic-
tionary (http://www. cardiacrehabilitation.org.uk/nacr/
downloads.htm), CR duration, ethnicity (white British/
other), relationship status (partnered/single), employ-
ment status (unemployed/employed/retired), history of
previous cardiac event (present/absent), treatment
received (revascularised/non-revascularisation), year
of initiating event and baseline anxiety and depression
score (for the CR wait time and post-CR outcome ana-
lyses only). As the data were clustered within CR cen-
tres we used cluster-robust standard errors to evaluate
the signiﬁcance of predictors. For the logistic and
multinomial regressions missing data were also imputed
via multiple imputation chained questions.35 The fol-
lowing variables were included in the imputation: age,
gender, ethnicity, number of comorbidities, employ-
ment status, relationship status, CR duration, history
of previous cardiac event, treatment received, year of
event, and baseline and post-CR HADS scores. Twenty
iterations were run and the quantity and pattern of
missing data was assessed prior to imputation (detail
presented in Table 1). To explore the relationship
between wait time and HADS, marginal probabilities
were calculated and explored visually. The amount of
variance due to data clustering by centre was also
explored using intraclass correlations for HADS
scores, wait time and CR duration. Post-estimation
checks were performed to investigate how well the stat-
istical models ﬁt to the data. Pearson chi-squared good-
ness-of-ﬁt tests were performed to test whether there is
a statistical diﬀerence between observed and expected
values (for multinomial logistic regressions this was
done using logistic regressions for all comparisons).
In addition, for the logistic model speciﬁcation tests
were run36 to test whether non-modelled non-linear
relationships were present.
Ethics
The NACR is hosted by NHS Digital, through which
designated researchers are approved to access anon-
ymised patient-level data related to CR delivery pro-
cesses and patient outcome pre and post-rehabilitation.
These agreements are assessed annually as part of data
governance approval between the NACR and NHS
Digital. The aforementioned agreements and anonymity
of the dataset meant that a separate ethical application
was not required as part of this study.
Results
Cohort characteristics
Patient characteristics are presented in Table 1. A total
of 39,588 patients completed CR and had a pre and
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post-CR HADS assessment. Participants were primarily
men, were British, with a mean age of 65 years. The
majority had at least one comorbidity, were in a relation-
ship, were retired, had undergone previous revascularisa-
tion surgery and a third of participants had experienced a
previous cardiac event. At baseline, 28% of patients had
some symptoms of anxiety and a further 17% had symp-
toms of depression. Between the pre and post-CR period
the proportion of symptomatic patients signiﬁcantly
decreased as well as the mean HADS scores.
In terms of data completion of the 56,233 patients who
started and completed CR and had a completed baseline
HADS assessment, 70% (n¼ 39,588) had a post CR
HADS assessment entered onto the NACR dataset.
Demographic characteristics between those who had a
missing post-CR HADS assessment (N¼ 16,557) and
those with a completed baseline and post-CR HADS
assessment were similar; mean age 65.1 versus 64.2
years and the proportions for remaining demographics
did not diﬀer by more than 5% (data not shown).
We assessed the size of the clustering eﬀect due to
centres on our core variables in this analysis by deter-
mining intraclass correlations (ICC), which describe the
amount of variance in these variables due to diﬀerences
between the rehabilitation centres. The ICC for
HADS depression scores at baseline was 0.02 (95%
CI 0.01–0.02) and post-CR was 0.02 (95% CI 0.01–
0.02), and the ICCs for HADS anxiety were 0.01
(95% CI 0.01–0.02) and 0.01 (95% CI 0.01–0.02) base-
line and post-CR, respectively. The ICCs for wait time
to start CR from referral (days) and CR programme
duration (days) were 0.14 (95% CI 0.10–0.17) and 0.23
(95% CI 0.18–0.28), respectively. ICCs were small for
HADS, indicating similar symptom distributions across
rehabilitation centres, but ICCs were high for wait time
and duration, which indicates by centre variation for
wait time and duration. Since it has long been estab-
lished that even small cluster eﬀects can have detrimen-
tal impacts on statistical models,37 we proceeded with
our strategy to use cluster-robust standard errors.
Participation in CR
The median wait time for starting CR ranged between
36 and 37 days in those with or without symptoms of
anxiety or depression. The duration of CR was 1 day
longer in those with symptoms of anxiety (58 days)
versus those without, and 4 days longer in those with
Table 1. Patient characteristics.
N¼ 39,588a
Mean age, years (SD) 65.1 (SD 10.60)
Gender, n men (%) n¼ 38,862 30,121 (78%)
Ethnicity, n British (%) n¼ 33,149 28,697 (87%)
One or more comorbidities, n (%) 29,326 (74%)
Employment status, n (%) n¼ 33,894
Employed 10,083 (30%)
Unemployed 5184 (15%)
Retired 18,627 (55%)
Marital status: partnered, n (%) n¼ 30,823 24,769 (80%)
Previous cardiac event, n (%) 13,108 (33%)
Undergone previous revascularisation, n (%) 34,410 (87%)
Median wait time to start CR from referral (days) 36 days (IQR 22, 57)
Mean wait time to start CR from referral (days) 45 days (SD 38.26)
Median CR programme duration (days) 59 days (IQR 47, 81)
Mean CR programme duration (days) 67 days (SD 35.78)
Baseline Post-CR
Symptoms of anxiety present, n (%) 11,015 (28%) 8394 (21%)*
Mean anxiety score (SD) 5.43 (4.04) 4.69 (3.77)*
Symptoms of depression present, n (%) 6734 (17%) 4637 (12%)*
Mean depression score (SD) 4.20 (3.50) 3.36 (3.22)*
SD: standard deviation; IQR: interquartile range; CR: cardiac rehabilitation.
aN¼ 39,588 unless otherwise stated.
N¼ 25,045 had data on all these variables.
*2 and t-test all P< 0.001.
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symptoms of depression (61 days) versus those without
(P< 0.001). The median wait time and CR duration are
presented by a change in HADS category from pre to
post-CR in Table 2. Wait time varied by no more than
2 and 4 days for change in HADS category for anxiety
and depression, respectively. Duration of CR varied
by 3 and 5 days for change in HADS anxiety and
depression category, respectively. The proportion of
non-completers was higher in those with symptoms
of anxiety 28% versus 23% and higher in those
with symptoms of depression 31% versus 23% in
non-symptomatic patients (both P< 0.001).
CR wait time and outcome
Tables 3 and 4 present the results of the logistic and
multinomial regression analyses. Statistically signiﬁcant
associations between HADS category (post-CR) and
CR wait time were observed, i.e. increasing CR wait
time increases the likelihood of symptomatic HADS
anxiety or depression scores (8) post-CR. At a wait
time of 28 days, the longest period starting CR would
still be seen as on time, the predicted probability of
being non-symptomatic for anxiety and depression
was 79% and 89% decreasing to 76% and 86% by
168 days (6 months from referral), respectively
(Figure 1). Testing model ﬁt, Pearson chi-squared
goodness-of-ﬁt tests were non-signiﬁcant (P¼ 0.92
and P¼ 0.90, respectively) and the speciﬁcation tests
revealed if at all only minor speciﬁcation error.
For change in the anxiety category the ﬁndings were
to the eﬀect that delayed or increasing CR wait time is
detrimental to mental health change from pre to post-
CR. Statistically signiﬁcant associations were observed
for those who changed from the symptomatic to
non-symptomatic category and those who remained
non-symptomatic and CR wait time. For change in
depression from pre to post-CR statistically signiﬁcant
associations were observed for those who changed from
symptomatic to non-symptomatic, those who remained
symptomatic and those who remained non-sympto-
matic and CR wait time. Testing model ﬁt, 14 of the
16 Pearson chi-squared goodness-of-ﬁt tests were
non-signiﬁcant (P> 0.39) indicating acceptable ﬁt, but
Table 3. Results from logistic regression: CR wait time (late CR or CR wait time in days) and likelihood of being symptomatic
following CR.
Observed data Imputed data
Anxiety
symptoms
OR (95% CI)
Depressive
symptoms
OR (95% CI)
Anxiety
symptoms
OR (95% CI)
Depressive
symptoms
OR (95% CI)
Late CR OR 1.13 P¼ 0.002
(1.04, 1.23)
OR 1.24 P< 0.001
(1.12, 1.38)
OR 1.04 P¼ 0.07
(0.99, 1.10)
OR 1.09 P¼ 0.01
(1.01, 1.001)
CR wait time OR 1.001 P¼ 0.001
(1.0008, 1.003)
OR 1.002 P< 0.001
(1.001, 1.003)
OR 1.0008 P¼ 0.02
(1.0001, 1.001)
OR 1.001 P¼ 0.001
(1.0004, 1.001)
CR: cardiac rehabilitation; OR: odds ratio; CI: confidence interval.
Analyses adjusted for age, gender, comorbidity, CR duration, ethnicity, relationship status, employment, history of previous cardiac event, treatment
received, baseline anxiety and depression score and year of initiating event.
Data were clustered with CR centres using cluster-robust standard errors.
Table 2. Median wait time and duration of CR by change in HADS anxiety and depression category.
Change in anxiety and depression
category from baseline to post-CR
Change in anxiety category Change in depression category
N (%)
Median wait
time (days)
Duration of
CR (days) N (%)
Median wait
time (days)
Duration
of CR (days)
Symptomatic to non-symptomatic 4,880 (12%) 35 61 3,694 (9%) 36 63
No change in symptomatic patients 6,135 (16%) 36 60 3,040 (8%) 40 61
Non-symptomatic to symptomatic 2,259 (6%) 36 63 1,597 (4%) 37 63
Remains non-symptomatic patient 26,314 (66%) 37 58 31,257 (79%) 36 58
CR: cardiac rehabilitation; HADS: hospital anxiety and depression scale.
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our model insuﬃciently predicted patients remaining
depressed (P¼ 0.002 and P¼ 0.03 for continuous and
dichotomised wait time models).
For the four anxiety and depression change cate-
gories: symptomatic to non-symptomatic, no change
in symptomatic patients, non-symptomatic to symp-
tomatic and remains non-symptomatic small changes
in the predicted probabilities over time were found.
For anxiety 12–10%, 14–17%, 5–7% and 67–64% at
a wait time of 28 days and 168 days (24 weeks
from referral), respectively. For depression 9%
(no change over time), 6–10%, 4% (no change over
time) and 79–75% at a wait time of 28 days and
168 days (24 weeks from referral), respectively (see
Supplementary material).
Tables 3 and 4 also present the results based on the
imputed data. These sensitivity analyses show that stat-
istically signiﬁcant associations between HADS cat-
egory (post-CR) and CR wait time were observed, i.e.
increasing CR wait time increases the likelihood of
symptomatic HADS anxiety or depression scores (8)
post-CR. For change in HADS category the ﬁndings
were to the eﬀect that delayed or increasing CR wait
time is detrimental to mental health change from pre to
post-CR; however, none of these eﬀects reached statis-
tical signiﬁcance.
Discussion
Current CR guidelines recommend the early com-
mencement of CR when appropriate.13,26,29,32,33
However, evidence shows large inconsistencies across
health regions and between patient groups, with
variation in wait times which can exceed the required
4-week time frame.31 Inconsistencies in practice are
concerning if there are implications to patient outcome.
In this study, we explored participation in CR in those
with and without symptoms of anxiety and depression
and the relationship between CR wait time and HADS
category (post HADS category and change in HADS
category) after CR. The results of this study showed
participation in CR varied by mental health status,
in particular signiﬁcantly lower completion rates
were observed in those who were symptomatic.
The likelihood of being classiﬁed as non-anxious or
non-depressed post-CR was also improved when the
commencement of CR was not delayed or had a
reduced wait time. The results from the observed
data, and in part from imputed data, support the
requirement for timely commencement of CR.
Furthermore, the sizable local practice variation,
evident through high ICC values for wait time and
programme duration, highlights that practices are not
uniform across centres, and that further investigation
of between-centre diﬀerences could play an importantT
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role to shed light on such delays or uncover new best
practice examples.
When comparing the participation in CR services by
HADS category at baseline and by change in HADS
category the variation in median wait time was limited.
However, wait time was still in excess of guidelines,
which recommend CR commencement within 4 weeks
of referral. As the data from these analyses has shown
and in a previous analysis of CR wait time and physical
activity outcomes,24 delays in starting CR can be detri-
mental to patient outcome so it is important to avoid
delays which are not driven by clinical necessity.
However, trials-based meta-analytical evidence has sug-
gested that later psychological treatment initiation (>2
months post event) is more beneﬁcial to mortality out-
comes than early initiation.38 This shows that further
research on the relationship between time to start of
CR (psychological treatment initiation speciﬁcally)
and a whole breadth of CR outcomes is needed.
In terms of the duration of CR some variation was
observed in those who were symptomatic at baseline (1
day extra if anxious, 4 days extra if depressed) and by
change in HADS category, e.g. those who remained
non-symptomatic undertook shorter CR programmes
than those who remained or developed mental health
symptoms. It is unknown whether this substantially
impacted patient care and outcome; however, the
median programme duration for the population with
HADS data (59 days) was below the recommended dur-
ation of CR, i.e. 12 weeks (84 days)29,30,33 and below
the 2016 national UK average of 63 days.31 Although
CR duration was longer in those who were symptom-
atic, the proportion of non-completers was also higher
in those who had symptoms of anxiety (5% higher drop
out) and in those with symptoms of depression (8%
higher drop out). This seems to ﬁt with previous
research, which has reported drop out from CR is
greater in those with higher anxiety and depression
scores.18
With regard to associations between CR wait time
and HADS outcome a relationship was observed in
these analyses to the eﬀect that the likelihood of
having symptoms of anxiety or depression post-CR
(HADS score 8) increases with every extra day
between referral and start of CR. Similar eﬀects were
also observed when investigating CR wait time in
accordance with guidelines deﬁning ‘early CR’ (deﬁned
as 0–28 days) with a 13–24% increase in the likelihood
of observing anxiety and depression symptoms follow-
ing ‘delayed’ CR. The signiﬁcant associations between
CR wait time and HADS outcome remained, albeit the
eﬀects were smaller, when using imputed data, except
when using timing as a categorical variable for anxiety,
which did not reach signiﬁcance. The impact of timing
on outcome was also reﬂected in the predicted prob-
ability of being non-symptomatic, which decreased over
time. Analyses by change in HADS category found sig-
niﬁcant associations for those changing from symptom-
atic and non-symptomatic for anxiety with both CR
timing variables and for depression with the categorical
timing variable only. As with the ﬁrst analysis increas-
ing or delayed CR wait time appears to impact change
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Figure 1. Predicted probability (%) of being non-symptomatic for anxiety and depression by wait-time (days).
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in outcome negatively. The results from the observed
data indicate that programmes which fall outside wait
time recommendations may inadvertently impact out-
come with respect to HADS. However, analyses of
change in HADS category using imputed data found
only a negative trend for those changing from symp-
tomatic and non-symptomatic for anxiety and depres-
sion with increasing or delayed CR wait time, and the
results did not reach signiﬁcance.
Although overall anxiety and depression scores were
shown to reduce from pre to post-CR, not all pro-
grammes enter post-CR assessments onto NACR. In
this study of those who had a baseline HADS score
and had completed CR, 30% did not have a post-CR
HADS score entered. A total of 21% of the population
remain anxious or develop symptoms of anxiety post-
CR (12% for depression), and this is associated with a
heightened risk of mortality and re-occurrence of car-
diovascular disease.19–22 Varying treatment
approaches, i.e. dose and duration, could be explored
to determine their impact on this subpopulation.
This study also highlights the need for improved
clinical data capture, one aim of the British
Association for Cardiovascular Prevention and
Rehabilitation (BACPR)/NACR certiﬁcation pro-
gramme.39 Pre and post assessments using measures
such as the HADS can be seen, by some, as posing a
substantial time burden on patients and services; how-
ever, a tailored intervention with guided long-term
management is the cornerstone of eﬀective CR.13,33
Newer technologies using computerised adaptive test-
ing systems that have been used successfully in similarly
challenging areas such as cancer/palliative care40,41 are
also under development for CR,42,43 and provide future
ways to less burdensome but accurate approaches to
assess patients’ mental health. Incentive-based
approaches to improve data capture could also be con-
sidered, but may not be the most powerful motivator as
noted in a recent report by the Healthcare Quality
Improvement Partnership (HQIP) on engaging clin-
icians in quality improvement through audit.44
Limitations
This UK-based analysis represents a large and current
investigation into the impact of CR wait time on anx-
iety and depression outcomes in routine practice, a
clear strength of this study. Known relevant confound-
ing variables and data clustering were managed eﬀect-
ively, although it is acknowledged that a measure of
disease severity was not included in this analysis as
this is not collected in NACR. The main limitation of
this analysis is the lack of consistent assessment and
documentation of mental health outcomes even for
audit purposes. Some of the missing data is due to par-
ticipants not completing their CR programme, thereby
missing follow-up assessment, while some is due to ser-
vices collecting outcomes with other measures
(including the PHQ-9 would have increased the
sample size by 983 and by 978 for GAD7 but the major-
ity of the loss is due to services’ documentation prac-
tices. As outlined in the introduction, mental health
outcomes merit attention, because they are predictive
of mid and long-term cardiac events including evidence
that depression and anxiety are diﬀerentially predictive
of these.8,9 For many patients post-CR data were not
available, which is troubling because our results show
that a sizable share of patients potentially deteriorate in
their mental health status (Table 2). Overall, this points
to the importance of ensuring high data quality in
audits for all clinically important variables. Finally,
the results of these analyses have only been determined
with one speciﬁc instrument, the HADS. In 2000 the
National Framework for Coronary Heart Disease was
published by the Department of Health, setting stand-
ards for modern practice including the use of HADS.45
Since then HADS has been the preferred clinical screen-
ing tool. Nevertheless, evidence is increasingly ques-
tioning whether the HADS is the most optimal choice
for screening;46,47 therefore, results need to be repli-
cated with other instruments.
Conclusions
Audit of CR services shows variation in service delivery
and in some cases practice, which falls outside of rec-
ommended guidelines. In these analyses, CR wait time
has been shown to predict the outcome of anxiety and
depression status to the extent that delays in starting
CR are detrimental. Programmes falling outside the 4-
week window for commencement of CR following
referral must strive to reduce wait times to avoid nega-
tive impacts to patient outcome.
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